Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD ... cancerous growths taken from the lining of the gut during endoscopy ...

Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.

Currently, there is insufficient evidence to allow any firm conclusions regarding the efficacy and safety of helminths used to treat patients with IBD ... or endoscopic improvement as defined by the ...

Aims: To describe the clinical features and outcomes of PSC-IBD and compare these to a group of chronic ... defined as the most proximal involvement of inflammatory disease based on histology or ...

Results Fifty-five per cent of patients achieving endoscopic ... IBD,3 it is not certain whether this is sufficient as an end point. Other therapies associated with significant healing, such as ...

Eli Lilly And Cao (NYSE:LLY) announced the results from the VIVID-2 open-label extension study of Omvoh (mirikizumab-mrkz).

In January, the FDA approved Omvoh for moderately to severely active Crohn's disease in adults. Omvoh is now approved in the U.S. for two types of inflammatory bowel disease (IBD), following its ...

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease monitoring by continuously measuring biomarkers in sweat, according to the creators ...

Pfefferkorn measured FL in CD patients scheduled for endoscopy or follow-up and ... screening tool in case of suspected IBD and a good marker of disease activity in patients with established ...